Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates

Stock News

2025/12/02

Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. ("Sikon Biological"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. ("Zhengzhou Biaoyuan"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.

The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1164625297"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164625297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164625297?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164625297","market":"sg","top_or_hot":-1,"title":"Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates","media":"Stock News","content":"<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAutobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-12-02 17:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09997","symbol_name":"康基醫療","start_time":0,"source_url":"","article_id":"1164625297","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164625297","pubTimestamp":1764668777,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","603658":"安图生物","09997":"康基医疗","BK0046":"生物疫苗","BK1583":"高瓴概念","BK0239":"医药制造","BK1100":"医疗保健设备","BK1222":"医疗保健用品","09996":"沛嘉医疗-B","BK1574":"生物医药B类股"},"translate_title":"奥特生物诊断（603658.SH）及子公司获得医疗器械注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"603658":1,"09996":1,"09997":1},"content_text":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.\nThe acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}